• Most Popular
  • Most Shared

More data needed for Glaxo's Advair-US FDA panel

Tue May 1, 2007 2:34pm EDT

Stocks

   

Regulatory News

WASHINGTON, May 1 (Reuters) - An increased risk of respiratory infections and pneumonia seen with GlaxoSmithKline Plc's (GSK.L)(GSK.N) high-dose Advair warrant further evaluation, a U.S. panel of experts unanimously said on Tuesday.

The U.S. Food and Drug Administration advisory panel earlier said company studies of the drug to treat chronic obstructive pulmonary disease, or COPD, showed it reduced flare-ups but does not help patients live longer.

((Reporting by Susan Heavey, editing by Martin Golan; Reuters Messaging: susan.heavey.reuters.com@reuters.net, Phone: 202-354-5848)) Keywords: GLAXOSMITHKLINE ADVAIR/STUDIES

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWBT006913



More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article